Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens
Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens
任务 A03：针对生物防御和新出现的传染病病原体的抗菌活性的体外筛选
批准号：
9928533
负责人：
RICHARD SLAYDEN
金额：
$15.74万
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-01-15 至 2020-09-30
关键词：
Advanced DevelopmentAnthrax diseaseAnti-Bacterial AgentsAntifungal AgentsAntimicrobial ResistanceBacillus anthracisBacteriaBiological AssayBurkholderia malleiBurkholderia pseudomalleiContractsDevelopmentEmerging Communicable DiseasesFrancisellaIn VitroMaintenanceMycotoxinsToxinTularemiaYersinia pestisbiodefensecombatfungusin vitro testingpathogenscreeningtherapeutic development
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testing of Drug Combinations For Mycobacterium tuberculosis (MTB) in Mice
-
批准号：10696863
-
项目类别：
-
资助金额：$125.03万
-
财政年份：2022
-
负责人：RICHARD SLAYDEN
-
依托单位：
Task A07: Anti-mycobacterial Target or Mechanism Identification contract (AToMIc)
-
批准号：10018974
-
项目类别：
-
资助金额：$88.07万
-
财政年份：2019
-
负责人：RICHARD SLAYDEN
-
依托单位：
Task A07: Anti-mycobacterial Target or Mechanism Identification contract (AToMIc)
-
批准号：10255792
-
项目类别：
-
资助金额：$5.26万
-
财政年份：2019
-
负责人：RICHARD SLAYDEN
-
依托单位：
Task A34: In vitro screening for antibacterial activity against biodefense and emerging infectious disease pathogens
-
批准号：9915362
-
项目类别：
-
资助金额：$1.66万
-
财政年份：2018
-
负责人：RICHARD SLAYDEN
-
依托单位：
TASK A30: In vitro screening for antibacterial activity against biodefense and emerging infectious disease pathogens
-
批准号：9566531
-
项目类别：
-
资助金额：$8.16万
-
财政年份：2017
-
负责人：RICHARD SLAYDEN
-
依托单位：
海外基金
